Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.135 USD | +0.07% | +7.07% | +6.27% |
May. 20 | Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating | MT |
May. 17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.27% | 2.68B | |
+30.65% | 470B | |
+32.74% | 276B | |
+4.30% | 135B | |
+30.50% | 94.76B | |
+62.83% | 61.13B | |
+13.79% | 46.6B | |
+25.78% | 38.08B | |
+0.03% | 35.74B | |
+12.27% | 29.13B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- Deutsche Bank Adjusts GoodRx Price Target to $9 From $7, Maintains Hold Rating